name: 'cellfree-rna-agent' description: 'AI-powered cell-free RNA analysis from liquid biopsy for cancer detection, tissue-of-origin identification, and non-invasive transcriptomic profiling.' measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes. allowed-tools:
- read_file
- run_shell_command
The Cell-Free RNA Analysis Agent provides comprehensive analysis of circulating cell-free RNA (cfRNA) from plasma and other biofluids for cancer detection, tissue-of-origin identification, and non-invasive transcriptomic profiling.
- When analyzing plasma cfRNA for cancer detection and monitoring.
- To identify tissue-of-origin from circulating transcripts.
- For non-invasive transcriptomic profiling of tumors.
- When integrating cfRNA with cfDNA for comprehensive liquid biopsy.
- To discover RNA-based biomarkers from accessible biofluids.
-
cfRNA Profiling: Quantify mRNA, lncRNA, and small RNA from plasma.
-
Tissue Deconvolution: Identify tissue sources contributing to cfRNA pool.
-
Cancer Detection: ML models detecting cancer from cfRNA profiles.
-
Tumor Transcriptomics: Infer tumor gene expression non-invasively.
-
Integration with cfDNA: Combine RNA and DNA liquid biopsy analytes.
-
Biomarker Discovery: Identify diagnostic and prognostic RNA markers.
Sources:
- Cell death (apoptosis, necrosis)
- Active secretion (EVs, RNA-binding proteins)
- Cell surface-associated RNA
Protection Mechanisms:
- Extracellular vesicles
- Protein complexes (AGO2, NPM1)
- Lipoproteins
Half-life: Minutes to hours (shorter than cfDNA)
-
Input: Plasma cfRNA sequencing data (total RNA, small RNA, or targeted).
-
Quality Control: Assess library complexity, mapping rates, contamination.
-
Quantification: Normalize and quantify transcripts.
-
Deconvolution: Estimate tissue contributions.
-
Classification: Apply cancer detection models.
-
Integration: Combine with cfDNA if available.
-
Output: Tissue composition, cancer score, biomarker profiles.
User: "Analyze plasma cfRNA to detect cancer and identify tissue of origin."
Agent Action:
python3 Skills/Genomics/CellFree_RNA_Agent/cfrna_analyzer.py \
--input plasma_cfrna.fastq.gz \
--protocol total_rna \
--reference gencode_v44 \
--deconvolution true \
--cancer_detection true \
--output cfrna_results/Reference Transcriptomes:
- GTEx tissue expression atlas
- Single-cell reference atlases
- Tissue-specific marker genes
Methods:
- Non-negative least squares
- Support vector regression
- Deep learning deconvolution
Clinical Applications:
- Organ injury detection (liver, heart, brain)
- Tumor burden estimation
- Post-transplant monitoring
| Cancer Type | Key Markers | Performance |
|---|---|---|
| Lung | XIST, MALAT1, specific mRNAs | AUC 0.80-0.90 |
| Breast | HER2, ER/PR transcripts | Monitoring |
| Colorectal | KRAS, panel genes | Early detection |
| Prostate | PCA3, TMPRSS2-ERG | Established |
| Liver | AFP, specific ncRNAs | HCC surveillance |
Pre-analytical Factors:
- Sample collection (EDTA, cell stabilization)
- Processing time (<4 hours recommended)
- Storage temperature (-80°C)
- Hemolysis avoidance (critical)
Library Preparation:
- Total RNA (captures mRNA, lncRNA)
- Small RNA (miRNA, piRNA)
- Targeted panels (specific genes)
- UMI-based for quantification
Cancer Classifier:
- Gradient boosting on gene panels
- Neural networks for full transcriptome
- Multi-cancer detection models
Tissue Predictor:
- Reference-based deconvolution
- Supervised tissue classifiers
- Anomaly detection for novel sources
| Analyte | Strength | Combination Benefit |
|---|---|---|
| cfDNA | Mutations, methylation | Genomic + transcriptomic |
| CTCs | Single-cell analysis | Cellular confirmation |
| Exosomes | Protected RNA | Source identification |
| Proteins | Functional markers | Multi-modal biomarkers |
- Python 3.10+
- STAR/Salmon for alignment
- DESeq2/edgeR for quantification
- Tissue deconvolution tools
- Liquid_Biopsy_Analytics_Agent - For comprehensive liquid biopsy
- Exosome_EV_Analysis_Agent - For EV-derived RNA
- ctDNA_Analysis - For DNA-based markers
- Targeted cfRNA: Gene panels for specific cancers
- Single-molecule: Direct RNA sequencing
- Spatial deconvolution: Mapping cfRNA to tissue regions
- Longitudinal monitoring: Treatment response tracking
AI Group - Biomedical AI Platform